SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2002

                            Commission File #0-30503

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)

                                     MONTANA
         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

                5161 San Felipe, Suite 320, Houston, Texas 77056
               (Address of principal executive offices)(Zip Code)

                                 (713) 933-0376
                (Registrant's telephone no., including area code)

    Consolidated Medical Management, Inc., 11829 Florida Blvd, Baton Rouge, LA
                                      70815
   (Former name, former address and former fiscal year, if changed since last
                                     report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.
Yes  [X]  No  [ ]

The  number  of shares outstanding of the Company's common stock as of March 31,
2002  is  shown  below:

Title of Class                                   Number of Shares Outstanding
Common Stock, par value $.001 per share          19,822,293

                    Documents Incorporated by Reference: None


<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1 - Financial Statements

Item 2 - Management's  Discussion  and Analysis of Financial Condition and
         Results of Operations

PART II - OTHER INFORMATION

Item 2 - Changes in Securities and Use of Proceeds

Item 6 - Reports on Form 8-K

SIGNATURES


<PAGE>
<TABLE>
<CAPTION>
                         PART I - FINANCIAL INFORMATION

Item 1.   Consolidated Financial Statements

                                  CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                         (A MONTANA CORPORATION)
                                   CONSOLIDATED STATEMENT OF CASH FLOWS
                                               (UNAUDITED)

                                                                          THREE MONTHS ENDED MARCH 31,
                                                                       ----------------------------------
                                                                             2002              2001
                                                                       -----------------  ---------------
<S>                                                                    <C>                <C>

Cash Flows from Operating Activities:
-------------------------------------
  Net Income (Loss)                                                    $       (220,386)  $      489,968
  Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by
       Operating Activities:
            Depreciation and Amortization                                             -                -
            Non Cash Consulting and Services Paid by Stock
            Issue                                                               146,000                -
            (Increase) Decrease in Receivables                                  (20,678)               -
            (Decrease) Increase in Accounts Payable                               5,012         (124,613)
            (Increase) Decrease in Interest Payable                              11,625           20,034
            (Increase) Decrease in Accrued Expenses                                   -                -
                                                                       -----------------  ---------------
                   Net Cash Provided (Used) by Operating Activities    $        (78,427)  $      385,389
                                                                       -----------------  ---------------

Cash Flows from Investing Activities:
-------------------------------------
  Note Receivable - Collections                                                  55,453
  Assets Disposed                                                                     -           17,415
                                                                       -----------------  ---------------
                   Net Cash Provided (Used) by Investing Activities    $         55,453   $       17,415
                                                                       -----------------  ---------------

Cash Flows from Financing Activities:
-------------------------------------

  Payments on Long-Term Debt                                                          -                -
  Proceed from Notes Payable                                                      7,600                -
  Common Stock                                                                   17,011         (404,000)
                                                                       -----------------  ---------------
                   Net Cash Provided (Used) by Financing Activities    $         24,611   $     (404,000)
                                                                       -----------------  ---------------
Net Increase (Decrease) in Cash                                        $          1,637   $       (1,196)

Cash, Beginning of period                                                         5,470            1,724
                                                                       -----------------  ---------------
Cash, End of period                                                    $          3,833   $          528
                                                                       =================  ===============

Supplemental Disclosure of Cash Flow Information
  Cash Paid During the Period for:
            Interest                                                   $              -   $          956
                                                                       =================  ===============
            Income Taxes                                               $              -   $            -
                                                                       =================  ===============
Supplemental Disclosure of Non-Cash Financing Information:
  In the quarter ended March 31, 2002 and 2001,
             Non Cash Consulting and Services Paid by Stock Issue      $        146,000   $            -
</TABLE>


<PAGE>
<TABLE>
<CAPTION>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
                             (A MONTANA CORPORATION)
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                   (UNAUDITED)

                                        THREE MONTHS ENDED MARCH 31,
                                    ----------------------------------
                                          2002              2001
                                    -----------------  ---------------
<S>                                 <C>                <C>
Revenues                            $              -   $            -
--------

Operating Expenses
     Personnel Costs                          43,563                -
     Consulting                              146,000                -
     Legal and Professional                   10,296           16,000
     Other Expenses                            8,902            1,429
                                    -----------------  ---------------
     Total Operating Expenses       $        208,761   $       17,429

Income (Loss) from Operations               (208,761)         (17,429)

Other Income (Expenses)
     Other                                         -          528,387
     Interest Expense                        (11,625)         (20,990)
     Interest Income                               -                -
                                    -----------------  ---------------
                                             (11,625)         507,397

Income (Loss) before Income
Taxes                               $       (220,386)  $      489,968

Income Tax Expense                                 -                -
                                    -----------------  ---------------
Net Income (Loss)                   $       (220,386)  $      489,968
                                    =================  ===============
Net Income (Loss) per Share         $        (0.0147)  $       0.0444
                                    =================  ===============
</TABLE>


<PAGE>
<TABLE>
<CAPTION>
                               CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                      (A MONTANA CORPORATION)
                                     CONSOLIDATED BALANCE SHEET
                                            (UNAUDITED)
                                               ASSETS
                                               ------

                                                               MARCH 31, 2002    DECEMBER 31, 2001
                                                              ----------------  -------------------
<S>                                                           <C>               <C>
Current Assets
--------------
Cash                                                          $         3,833   $            5,470
Note Receivable - Options                                             560,039              396,003
                                                              ----------------  -------------------
     Total Current Assets                                             563,872              401,473

Other Assets                                                                -                    -
                                                              ----------------  -------------------
     Total Assets                                             $       563,872   $          401,473
                                                              ================  ===================


                              LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                              ----------------------------------------------

Current Liabilities
-------------------
Notes Payable-Current Portion                                 $        33,367   $           25,767
Accounts Payable                                                      113,024              108,012
Accrued Expenses                                                      208,255              196,630
Convertible Debentures                                                465,000              465,000
    and Notes Payable-Current Portion
                                                              ----------------  -------------------
     Total Current Liabilities                                        819,646              795,409

Notes Payable - Long Term Portion                                      54,726               54,726
    Long-Term Portion
                                                              ----------------  -------------------
     Total Long-Term Liabilities                                       54,726               54,726

     Total Liabilities                                        $       874,372   $          850,135

Commitments and Contingencies:                                                                   -
-----------------------------

Stockholders' Equity
--------------------
Common Stock                                                  $        14,987   $           13,591
  $0.001 par value, 50,000,000 shares authorized 14,987,347
  shares issued and outstanding as of March 31, 2002 and
  13,587,293 shares issued and outstanding as of December
  31, 2001.

Additional Paid-in-Capital                                          3,910,213            3,553,061
Retained Earnings (Deficit)                                        (4,235,700)          (4,015,314)
                                                              ----------------  -------------------
          Total Stockholders' Equity (Deficit)                       (310,500)            (448,662)
                                                              ----------------  -------------------
          Total Liabilities and Stockholders' Equity
          (Deficit)                                           $       563,872   $          401,473
                                                              ================  ===================
</TABLE>


<PAGE>
PART I - FINANCIAL INFORMATION
------------------------------

                          ITEM 1. FINANCIAL STATEMENTS

AS  USED  HEREIN,  THE  TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC.  INC.  UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL
STATEMENTS  INCLUDING  A  BALANCE  SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
MARCH  31,  2002,  STATEMENT  OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY  THIS  REFERENCE.




                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]



<PAGE>
                    Consolidated Medical Management Inc. Inc.
                          Notes to Financial Statements

NOTE 1- BASIS OF PRESENTATION
-----------------------------

GENERAL
-------
The  consolidated  unaudited  interim  financial statements of the Company as of
March  31,  2002  and for the three months ended March 31, 2002, included herein
have  been prepared in accordance with the instructions for Form 10QSB under the
Securities  Exchange  Act  of 1934, as amended, and Article 10 of Regulation S-X
under the Securities Act of 1933, as amended. The December 31, 2001 Consolidated
Balance  Sheet  was  derived  from  audited  financial  statements, but does not
include  all  disclosures  required by generally accepted accounting principles.
Certain  information  and  note  disclosures  normally  included  in  financial
statements  prepared in accordance with generally accepted accounting principles
have  been  condensed or omitted pursuant to such rules and regulations relating
to  interim  consolidated  financial  statements.

In  the  opinion  of management, the accompanying consolidated unaudited interim
financial  statements  reflect  all  adjustments,  consisting  only  of  normal
recurring adjustments, necessary to present fairly the financial position of the
Company  at  March  31,  2002, and the results of their operations for the three
months  ended March 31, 2002 and from inception to March 31 2002, and their cash
flows  for the three months ended March 31, 2002 and from inception to March 31,
2002.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2001and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission

                                  Organization
The Company was incorporated under the laws of the State of Montana on August
13, 1981.  The Company ceased its mining operations in 1985, and discontinued
all business operations in 1990.  In August of 2001, the Company decided to
refocus on the oil and gas industry and entered into several Letters of Intent
only one of which survived the due diligence process.  Currently, the Company is
signed a letter of intent to acquire revenue producing properties in Runnels
County, Texas.  There is no assurance that the acquisition will be finalized.


<PAGE>
                   Consolidated Medical Management Inc., Inc.
                          Notes to Financial Statements

NOTE 2  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
-----------------------------------------------------
ACCOUNTING METHOD
-----------------
Accounting  policies of the Company conform to the generally accepted accounting
principles  and  reflect  practices  appropriate  to  the  industry  in which it
operates.  The  significant  policies  are  summarized  below.

     -    RECEIVABLES

     The  Company,  through an S-8 offering, grants options and stock to several
     individuals  for  stock.  As of March 31, 2002 and December 31, 2001, there
     was  $ 560,039 and $396,003 owed to the Company for stock purchased through
     the  S-8  stock  program.

     -    PROPERTY,  EQUIPMENT  AND  DEPRECIATION

     Expenditures  for  property,  plant  and  equipment  are  recorded at cost.
     Renewals  and  improvements, which extend the economic life of such assets,
     are  capitalized.  Expenditures for maintenance, repairs and other renewals
     are  charged  to  expense. For major dispositions, the cost and accumulated
     depreciation are removed from the accounts and any gain or loss is included
     in  the  results of operations. During the year 2001, the Company abandoned
     the remaining assets relating to the healthcare operations in the amount of
     $17,415.

     -    CASH  FLOWS  AND  CONCENTRATION  OF  CREDIT  RISK

     Cash  consists  principally  of  demand deposits at commercial banks. These
     balances,  as  reflected  in the bank's records, are insured by the Federal
     Deposit  Insurance  Corporation  up  to  $100,000. At December 31, 2001 and
     March  31,  2002, the Company's deposits did not exceed the insured limits.

During  2000,  the Company adopted the U.S. Securities and Exchange Commission's
("SEC")  Staff Accounting Bulletin 101, "Revenue Recognition" ("SAB 101"), which
provides guidance on the recognition, presentation, and disclosure of revenue in
financial  statements filed with the SEC. The adoption of SAB 101 did not have a
material  effect  on  the  Company's  business,  financial condition, results of
operations or cash flows. The Company believes that SAB 101 has been followed in
the  recognition  of  revenues.

EARNINGS PER COMMON SHARE
-------------------------
The  Company adopted Financial Accounting Standards  (SFAS) No.  128,  "Earnings
Per Share," which simplifies the computation of earnings per share requiring the
restatement  of  all  prior  periods.

Basic  earnings  per  share  are  computed  on the basis of the weighted average
number  of  common  shares  outstanding  during  each  year.

Diluted  earnings  per  share  are computed on the basis of the weighted average
number  of  common  shares  and  dilutive  securities  outstanding.  Dilutive
securities  having  an  anti-dilutive  effect  on diluted earnings per share are
excluded  from  the  calculation.  The  Company  does  not  have  any  dilutive
securities  as  of  March  31,  2002.


<PAGE>
                   Consolidated Medical Management Inc., Inc.
                          Notes to Financial Statements


NOTE 3  -  CONVERTIBLE DEBENTURES AND NOTES PAYABLE
---------------------------------------------------

The Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases.  The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent, interest is payable in monthly installments.  Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the Company's common stock at the greater of $2.50 per share or ninety (90%)
percent of the bid price, whichever is greater on the date of conversion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion.  The debentures are due one year from date of
issue. All debentures issued in 1998 were due in 1999, and they are in default
as of March 31, 2002.

The Company issued convertible promissory notes payable in 1998.  The notes are
unsecured and include interest at ten (10%) percent, interest is payable in
monthly installments.  Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. As of December 31, the company had issued and
outstanding $325,000 in debentures.  The notes were due July 31, 1999, and they
are in default as of March 31 2002.

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.  In exchange,
Spectrum will then receive an unsecured note payable from the Company (see Note
7) for the face amount of the debenture surrendered.  During the year ended
December 31, 1998, Spectrum exchanged a total of 14,000 of its shares in
connection with this agreement and received five notes payable from the Company
totaling $35,000.



     Total Convertible Debentures and Notes Payable      $       465,000
     Less: Current Portion                                      (465,000
                                                         ---------------
     Long-Term Portion                                   $            -0
                                                         ===============

NOTE  4  -  COMMON  AND  PREFERRED  STOCK
-----------------------------------------

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of as of December 31, 2001 and March 31, 2002, the Company had
13,587,293 and 14,987,293 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $ 0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares.  As of
March 31, 2002 and December 31, 2001 there are no shares issued and outstanding.


<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


NOTE  4  -  COMMON  AND  PREFERRED  STOCK  (CONTINUATION)
---------------------------------------------------------

DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such  respective dividend payment date.  In no event
shall the holders of either series receive dividends of more than percent (1%)
in any fiscal year.  Each share of both series shall rank on parity with each
other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" of $ 12.50 Preferred Stock.  The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.

NOTE 5 - COMMITMENT AND CONTINGENCIES

The Company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing operating costs of the Company interest free


<PAGE>
Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.

The following discussion should be read in conjunction with our unaudited
consolidated interim financial statements and related notes thereto included in
this quarterly report and in our audited consolidated financial statements and
Management's Discussion and Analysis of Financial Condition and Results of
Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31,
2001. Certain statements in the following MD&A are forward looking statements.
Words such as "expects", "anticipates", "estimates" and similar expressions are
intended to identify forward looking statements. Such statements are subject to
risks and uncertainties that could cause actual results to differ materially
from those projected.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2002 COMPARED TO THE
-------------------------------------------------------------------------------
THREE MONTHS ENDED MARCH 31, 2001
---------------------------------

For the quarter ended March 31, 2002, our net loss was $(220,386) as compared to
$489,968 for the quarter ended March 31, 2001. Our net loss during the quarter
ended March 31, 2002 increased dramatically, primarily as the result of stock
options issued to consultants to assist us in developing a focused business plan
and strategy for obtaining the debt or equity financing that we will need to
acquire energy prospects. We have relied on key stockholders and officers to
bear the substantial costs that are involved in positioning our company to
commence commercial operations. We expect to continue to incur losses and face
cash flow problems for a period that could extend for several years.

We believe that we will need to raise cash of at least $50,000 to continue our
operations through the end of 2002. The success of fund raising efforts and our
ability to use our common stock to complete the acquisition of assets and/or
facilities will have a significant impact on the extent of our fund raising
efforts.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

During the year ended December 31, 2001, we experienced negative financial
results which have continued during the three months ended March 31, 2002 as
follows:
                                                  THREE MONTHS    THREE MONTHS
                                                     ENDED           ENDED
                                                   MARCH 31,        MARCH 31,
                                                     2002            2001
                                                --------------  --------------
Net loss                                        $  (220,386)    $     489,968

Negative working capital                           (819,646)         (795,409)

Accumulated deficit                              (4,235,700)       (4,015,314)


<PAGE>
In addition to its negative financial results, we have significant accrued
liabilities, accounts payable and obligation to stockholders for expenses that
they have paid on behalf of our Company.

As a development stage company, Consolidated has not generated any revenue and
has been dependent on debt and equity raised from individual investors to
sustain its operations. During the three months ended March 31, 2002, the
Company incurred a net loss of $(220,386) compared to net income of $489,968 for
the three months ended March 31, 2001. At March 31, 2002 the Company had
negative working capital of $(819,646). These factors raise substantial doubt
about the Company's ability to continue as a going concern.

The Company is currently considering a public sale or private placement of its
common stock if an active trading market for its existing outstanding shares can
be established. The Company is attempting to finalize an energy acquisition
which would be revenue producing.  They are in discussions to raise the required
funding. However, such sources of funding may be unavailable. The Company's
long-term viability as a going concern is dependent on certain key factors as
follows:

- The Company's ability to obtain adequate sources of funding to continue the
implementation of its business strategy. Sources of funding may not be available
on terms that are acceptable to the Company and existing stockholders, or may
include terms that will result in substantial dilution to existing stockholders.

- The ability of the Company to find suitable energy prospects to establish a
revenue base.

- The ability of the Company to ultimately achieve adequate profitability and
strong operating cash flows to sustain its operations

- The ability to obtain adequate sources of funding to continue the
implementation of our

As a result of the liquidity issues facing the Company, the Company's
independent accountant included an emphasis paragraph in his report for the year
ended December 31, 2001 that addresses the substantial doubt that exists as to
the Company's ability to continue as a going concern.

The statements contained herein and other information contained in this report
may be based, in part, on management's estimates, projections, plans and
judgments. As such, these are forward looking statements and involve a number of
risks and uncertainties. A number of factors, which could cause actual results
to differ materially, include: general economic conditions, competitive market
influences, technology changes, and other influences beyond the control of
management. This report contains a number of forward-looking statements, which
reflect the Company's current views with respect to future events and financial
performance including statements regarding the Company's projections. These
forward-looking statements are subject to certain risks and uncertainties that
could cause actual results to differ materially from historical results or those
anticipated. In this report, the words "anticipates", "believes", "expects",
"intends", "future", "plans", "targets" and similar expressions identify
forward-looking statements.


<PAGE>
Readers are cautioned to not place undue reliance on the forward-looking
statements contained herein, which speak only as of the date hereof. The Company
undertakes no obligation to publicly revise these forward-looking statements, to
reflect events or circumstances that may arise after the date hereof.
Additionally, these statements are based on certain assumptions that may prove
to be erroneous and are subject to certain risks including, but not limited to,
the Company's dependence on limited cash resources, and its dependence on
certain key personnel within the Company. Accordingly, actual results may
differ, possibly materially, from the predictions contained herein.


                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.

Item 2.  Changes in Securities

The following information sets forth certain information as of March 31, 2002,
for all securities the Company sold since July 1, 2000, without registration
under the Act, excluding any information "previously reported as defined in Rule
12B-2 of the Securities Exchange Act of 1934."  There were no underwriters in
any of these transactions, nor were any sales commissions paid thereon.

Item 4.  Submission of Matters to a Vote of Security Holders.

None

Item 6.  Exhibits and Reports on Form 8-K
     (a)  Exhibits - None
     (b)  Reports  on  Form  8-K -- None


<PAGE>
                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of
Houston, Texas, on May 20, 2002.

CONSOLIDATED MEDICAL MANGEMENT, INC.

By: /s/ Timothy G. Byrd, Sr.




-----------------------------------------
     Timothy G. Byrd, Sr. Chief Executive Officer, and Director


Pursuant to the requirements of the Securities Exchange Act of 1933, this 10-QSB
has been signed below by the following persons on behalf of the registrant in
the capacities and on the date indicated.

Signature                         Name and Title                    Date
----
/s/ Sonny Wooley         Chairman of the Board of Directors      May 20, 2001




-------------------

/s/ Timothy G. Byrd     Chief Executive Officer, and Director    May 20, 2001





-----------------

/s/ Peggy Behrens              Secretary                         May 20, 2001




-----------------


<PAGE>